I型干扰素信号增强神经炎光学谱障碍中的自身免疫力
Tian-Xiang Zhang1, Xiaoxiao Yang2, Xue Gao1
1Department of Neurology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|July 21, 2025
概括
神经脊髓炎光学谱系障碍 (NMOSD) 涉及异常的免疫细胞信号传递. 在NMOSD模型中,抑制cGAS-STING-IFN-I通路会减少自身免疫反应和疾病严重程度.
科学领域:
- 神经免疫学 神经免疫学
- 自身免疫性疾病 自身免疫性疾病
- 细胞信号传输 细胞信号传输
背景情况:
- 神经脊髓炎光学谱系障碍 (NMOSD) 是一种针对水素4 (AQP4) 的自身免疫性星细胞病,治疗干扰素β (IFN-β) 失败的机制尚不清楚.
- 在NMOSD中的骨髓状细胞表现出循环GMP-AMP合成酶 (cGAS) - - 干扰素基因 (STING) - - 干扰素I型 (IFN-I) 信号通路的强烈激活.
研究的目的:
- 研究cGAS-STING-IFN-I通路在NMOSD病原发生中的作用.
- 探索向这种途径用于NMOSD治疗的治疗潜力.
主要方法:
- 对从NMOSD患者和小鼠模型的髓状细胞中cGAS-STING-IFN-I通路激活的分析.
- 评估AQP4特异性T细胞反应和STING缺陷小鼠中的天体细胞损伤.
- 在NMOSD小鼠模型中评估STING抑制剂H151的疗效.
主要成果:
- 在NMOSD中,cGAS-STING-IFN-I通路在髓状细胞中被强烈激活,导致AQP4特异性自身反应性T细胞的增加.
- 在小鼠模型中,STING缺陷显著降低了T细胞激活,微质中的IFN-I活性和天体细胞损伤,改善了NMOSD临床表现.
- 在小鼠模型中,使用STING抑制剂H151治疗可缓解NMOSD的严重程度.
结论:
- cGAS-STING-IFN-I通路在NMOSD中促进自身反应性T细胞中发挥着关键作用.
- 抑制cGAS-STING-IFN-I通路代表了NMOSD的一个有前途的新疗法策略.
更多相关视频
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
12.4K
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.6K
相关概念视频
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
